Related Experiment Video

Updated: Sep 20, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.9K

Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy

Yanfeng Gao1, Xuanming Yang2, Bin Zhang3

  • 1School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.

Frontiers in Immunology
|June 6, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cancer immunotherapydrug repositioningimmune checkpointinnate immunitysmall molecular inhibitor

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

718
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.6K

Related Concept Videos